Nakagawa M - Search Results

1

The role of microRNAs in bladder cancer.

Enokida H, Yoshino H, Matsushita R, Nakagawa M. Enokida H, et al. Among authors: nakagawa m. Investig Clin Urol. 2016 Jun;57 Suppl 1(Suppl 1):S60-76. doi: 10.4111/icu.2016.57.S1.S60. Epub 2016 Jun 7. Investig Clin Urol. 2016. PMID: 27326409 Free PMC article. Review.

2

Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.

Yoshino H, Enokida H, Osako Y, Nohata N, Yonemori M, Sugita S, Kuroshima K, Tsuruda M, Tatarano S, Nakagawa M. Yoshino H, et al. Among authors: nakagawa m. Mol Oncol. 2020 Sep;14(9):2190-2202. doi: 10.1002/1878-0261.12697. Epub 2020 Jun 20. Mol Oncol. 2020. PMID: 32386122 Free PMC article.

3

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.

Okamura S, Yoshino H, Kuroshima K, Tsuruda M, Osako Y, Sakaguchi T, Yonemori M, Yamada Y, Tatarano S, Nakagawa M, Enokida H. Okamura S, et al. Among authors: nakagawa m. BMC Cancer. 2021 Jan 11;21(1):48. doi: 10.1186/s12885-020-07717-0. BMC Cancer. 2021. PMID: 33430801 Free PMC article.

4

microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1.

Tamai M, Tatarano S, Okamura S, Fukumoto W, Kawakami I, Osako Y, Sakaguchi T, Sugita S, Yonemori M, Yamada Y, Nakagawa M, Enokida H, Yoshino H. Tamai M, et al. Among authors: nakagawa m. Mol Oncol. 2022 Mar;16(6):1329-1346. doi: 10.1002/1878-0261.13192. Epub 2022 Feb 28. Mol Oncol. 2022. PMID: 35148461 Free PMC article.

5

Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.

Kawakami K, Enokida H, Tachiwada T, Gotanda T, Tsuneyoshi K, Kubo H, Nishiyama K, Takiguchi M, Nakagawa M, Seki N. Kawakami K, et al. Among authors: nakagawa m. Oncol Rep. 2006 Sep;16(3):521-31. Oncol Rep. 2006. PMID: 16865252

6

Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma.

Kawakami K, Enokida H, Tachiwada T, Nishiyama K, Seki N, Nakagawa M. Kawakami K, et al. Among authors: nakagawa m. J Urol. 2007 Jul;178(1):301-7. doi: 10.1016/j.juro.2007.03.002. Epub 2007 May 17. J Urol. 2007. PMID: 17499794

7

Epigenetics in bladder cancer.

Enokida H, Nakagawa M. Enokida H, et al. Among authors: nakagawa m. Int J Clin Oncol. 2008 Aug;13(4):298-307. doi: 10.1007/s10147-008-0811-1. Epub 2008 Aug 15. Int J Clin Oncol. 2008. PMID: 18704629 Review.

8

Identification of novel microRNA targets based on microRNA signatures in bladder cancer.

Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N. Ichimi T, et al. Among authors: nakagawa m. Int J Cancer. 2009 Jul 15;125(2):345-52. doi: 10.1002/ijc.24390. Int J Cancer. 2009. PMID: 19378336

9

Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.

Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M. Chiyomaru T, et al. Among authors: nakagawa m. Urol Oncol. 2012 Jul-Aug;30(4):434-43. doi: 10.1016/j.urolonc.2010.05.008. Epub 2010 Sep 16. Urol Oncol. 2012. PMID: 20843712

10

CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.

Toki K, Enokida H, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M. Toki K, et al. Among authors: nakagawa m. Int J Oncol. 2010 Dec;37(6):1379-88. doi: 10.3892/ijo_00000789. Int J Oncol. 2010. PMID: 21042705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,025 results

Search Page

Filters